sleep drugs

Bed floating on a cloud with the full moon behind it
Biotech

Apnimed's sleep apnea star goes 2 for 2 in phase 3

Patients receiving AD109 had a 46.8% reduction in a measure of sleep apnea severity, highlighting the asset's potential to treat the common condition.
Darren Incorvaia Jul 23, 2025 6:00am
Comfy bed sitting on pink clouds

Apnimed eyes FDA sleep apnea submission after positive results

May 19, 2025 6:00am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Phase 2b narcolepsy win powers Takeda toward pivotal trials

Feb 9, 2024 6:02am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Jazz halts sleep disorder med trial over 'visual disturbances'

Nov 29, 2023 10:50am
People shaking hands across a desk that has computer and papers on it

Jazz pays $50M for rights to early-phase narcolepsy prospect

May 5, 2022 8:30am
Man with insomnia in bed

Apnimed secures $62.5M to push sleep disorder drug development

May 4, 2022 10:22am